Literature DB >> 9082585

[p53 status in breast carcinomas and the effect of adjuvant radio- and chemotherapies].

C Richter, J Dunst.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9082585     DOI： 10.1007/bf03039194

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  3 in total

1.  Radiotherapy, chemotherapy, and tamoxifen as adjuncts to surgery in early breast cancer: a summary of three randomized trials.

Authors:  L E Rutqvist; B Cedermark; U Glas; H Johansson; S Rotstein; L Skoog; A Somell; T Theve; J Askergren; S Friberg
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-03       Impact factor: 7.038

2.  p53 expression and the result of adjuvant therapy of breast cancer.

Authors:  O Stål; M Stenmark Askmalm; S Wingren; L E Rutqvist; L Skoog; L Ferraud; S Sullivan; J Carstensen; B Nordenskjöld
Journal:  Acta Oncol       Date:  1995       Impact factor: 4.089

3.  S-phase fraction and survival benefit from adjuvant chemotherapy or radiotherapy of breast cancer.

Authors:  O Stål; L Skoog; L E Rutqvist; J M Carstensen; S Wingren; S Sullivan; A C Andersson; M Dufmats; B Nordenskjöld
Journal:  Br J Cancer       Date:  1994-12       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.